Switch to:
Sanofi (NYSE:SNY)
Research and Development
$6,331 Mil (TTM As of Sep. 2014)

This is the expense the company spent on research and development. Sanofi's research and development for the three months ended in Sep. 2014 was $1,452 Mil. Its research and development for the trailing twelve months (TTM) ended in Sep. 2014 was $6,331 Mil.


Definition

This is the expense the company spent on research and development.

Sanofi Research & Development for the trailing twelve months (TTM) ended in Sep. 2014 was 1697.54768392 (Dec. 2013 ) + 1573.20441989 (Mar. 2014 ) + 1607.57780785 (Jun. 2014 ) + 1452.47148289 (Sep. 2014 ) = $6,331 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Related Terms

Gross Profit


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Sanofi Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
Research & Development 3,1334,9045,7546,6826,0606,5385,8846,2086,5456,499

Sanofi Quarterly Data

Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14Jun14Sep14
Research & Development 1,5221,4841,8011,5081,5511,6131,6981,5731,6081,452
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK